乳腺癌患者使用紫杉类化疗药物后引起周围神经病变的相关预防和治疗措施
Prevention and Treatment Measures Related to Peripheral Neuropathy Caused by Paclitaxel-Based Chemotherapy Drugs in Breast Cancer Patients
DOI: 10.12677/ACM.2022.127919, PDF,   
作者: 张 瑾*, 达梦婷, 袁明雪:青海大学,青海 西宁;沈国双#:青海大学附属医院乳腺疾病诊疗中心,青海 西宁
关键词: 乳腺癌紫杉类药物化疗导致的周围神经病变Breast Cancer Paclitaxel-Based Chemotherapy-Induced Peripheral Neuropathy
摘要: 乳腺癌是全球女性发病率第一的癌种,严重影响女性健康。化学治疗作为其重要的治疗方式之一,占据着不可撼动的地位;其中,紫杉类药物作为乳腺癌化学治疗的基石之一,其诱导的周围神经病变可导致化疗中止,影响疗效,甚至影响患者日后的生活质量。目前临床上尚未有明确的预防或治疗标准,是该领域一直难以攻克的问题。本文就目前紫杉类药物导致乳腺癌患者周围神经毒性的预防和治疗方法做一综述,以期为今后的临床研究提供一定的依据。
Abstract: Breast cancer is the most prevalent cancer among women worldwide and seriously affects women’s health. Chemotherapy occupies an unassailable position as one of its important treatment modali-ties. Peripheral neuropathy induced by paclitaxel, one of the cornerstones of chemotherapy for breast cancer, can lead to discontinuation of chemotherapy, affecting the efficacy and even the qual-ity of life of patients later in life. There is no clear clinical standard for prevention or treatment, and it is a problem that has been difficult to overcome in this field. This article reviews the current methods of prevention and treatment of peripheral neurotoxicity caused by paclitaxel in breast cancer patients, with the aim of providing some basis for future clinical studies.
文章引用:张瑾, 达梦婷, 袁明雪, 沈国双. 乳腺癌患者使用紫杉类化疗药物后引起周围神经病变的相关预防和治疗措施[J]. 临床医学进展, 2022, 12(7): 6377-6383. https://doi.org/10.12677/ACM.2022.127919

参考文献

[1] Sung, H., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[2] Mcdonald, E.S., Clark, A.S., Tchou, J., et al. (2016) Clinical Diagnosis and Management of Breast Cancer. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine, 57, 9S-16S. [Google Scholar] [CrossRef] [PubMed]
[3] Burstein, H.J., Curigliano, G., Thürlimann, B., et al. (2021) Cus-tomizing Local and Systemic Therapies for Women with Early Breast Cancer: The St. Gallen International Consensus Guidelines for Treatment of Early Breast Cancer 2021. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 32, 1216-1235.
[4] Staff, N.P., Grisold, A., Grisold, W., et al. (2017) Chemotherapy-Induced Pe-ripheral Neuropathy: A Current Review. Annals of Neurology, 81, 772-781. [Google Scholar] [CrossRef] [PubMed]
[5] Lluch, A., et al. (2014) Treatment Innovations for Metastatic Breast Cancer: Nanoparticle Albumin-Bound (NAB) Technology Targeted to Tumors. Critical Reviews in Oncology/Hematology, 89, 62-72. [Google Scholar] [CrossRef] [PubMed]
[6] Gornstein, E.L. and Schwarz, T.L. (2017) Neurotoxic Mech-anisms of Paclitaxel Are Local to the Distal Axon and Independent of Transport Defects. Experimental Neurology, 288, 153-166. [Google Scholar] [CrossRef] [PubMed]
[7] Duggett, N.A., Griffiths, L.A. and Flatters, S.J.L. (2017) Paclitaxel-Induced Painful Neuropathy Is Associated with Changes in Mitochondrial Bioenergetics, Glycolysis, and an Energy Deficit in Dorsal Root Ganglia Neurons. Pain, 158, 1499-1508. [Google Scholar] [CrossRef] [PubMed]
[8] Griffiths, L.A. and Flatters, S.J.L. (2015) Pharmacological Modulation of the Mitochondrial Electron Transport Chain in Paclitaxel-Induced Painful Peripheral Neuropathy. The Journal of Pain, 16, 981-994. [Google Scholar] [CrossRef] [PubMed]
[9] Gornstein, E. and Schwarz, T.L. (2014) The Paradox of Paclitaxel Neurotoxicity: Mechanisms and Unanswered Questions. Neuropharmacology, 76, 175-183. [Google Scholar] [CrossRef] [PubMed]
[10] Boyette-Davis, J., Xin, W., Zhang, H., et al. (2011) In-traepidermal Nerve Fiber Loss Corresponds to the Development of Taxol-Induced Hyperalgesia and Can Be Prevented by Treatment with Minocycline. Pain, 152, 308-313. [Google Scholar] [CrossRef] [PubMed]
[11] Mironov, S.L., Ivannikov, M.V. and Johansson, M. (2005) [Ca2+]i Signaling between Mitochondria and Endoplasmic Reticulum in Neurons Is Regulated by Microtubules. From Mito-chondrial Permeability Transition Pore to Ca2+- Induced Ca2+ Release. The Journal of Biological Chemistry, 280, 715-721. [Google Scholar] [CrossRef
[12] Seretny, M., Currie, G.L., Sena, E.S., et al. (2014) Incidence, Preva-lence, and Predictors of Chemotherapy-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis. Pain, 155, 2461-2470. [Google Scholar] [CrossRef] [PubMed]
[13] Bao, T., et al. (2016) Long-Term Chemotherapy-Induced Peripheral Neuropathy among Breast Cancer Survivors: Prevalence, Risk Factors, and Fall Risk. Breast Cancer Research and Treatment, 159, 327-333. [Google Scholar] [CrossRef] [PubMed]
[14] Bandos, H., et al. (2018) Long-Term Peripheral Neuropathy in Breast Cancer Patients Treated with Adjuvant Chemotherapy: NRG Oncology/NSABP B-30. Journal of the National Cancer Institute, 110, djx162. [Google Scholar] [CrossRef] [PubMed]
[15] Tanabe, Y., et al. (2013) Paclitaxel-Induced Peripheral Neuropathy in Pa-tients Receiving Adjuvant Chemotherapy for Breast Cancer. International Journal of Clinical Oncology, 18, 132-138.
[16] Simon, N.B., et al. (2017) The Prevalence and Pattern of Chemotherapy-Induced Peripheral Neuropathy among Women with Breast Cancer Receiving Care in a Large Community Oncology Practice. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 26, 2763-2772. [Google Scholar] [CrossRef] [PubMed]
[17] Rivera, E. and Cianfrocca, M. (2015) Overview of Neuropathy Associated with Taxanes for the Treatment of Metastatic Breast Cancer. Cancer Chemotherapy and Pharmacology, 75, 659-670. [Google Scholar] [CrossRef] [PubMed]
[18] Rashid, N., Koh, H.A., Baca, H.C., et al. (2015) Clinical Impact of Chemotherapy-Related Adverse Events in Patients with Metastatic Breast Cancer in an Integrated Health Care System. Journal of Managed Care & Specialty Pharmacy, 21, 863-871. [Google Scholar] [CrossRef] [PubMed]
[19] Hershman, D.L., et al. (2014) Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 32, 1941-1967.
[20] Eckhoff, L., et al. (2013) Risk of Docetaxel-Induced Peripheral Neuropathy among 1,725 Danish Patients with Early Stage Breast Cancer. Breast Cancer Research and Treatment, 142, 109-118. [Google Scholar] [CrossRef] [PubMed]
[21] Tsuyuki, S., et al. (2016) Evaluation of the Effect of Compression Therapy Using Surgical Gloves on Nanoparticle Albumin-Bound Paclitaxel-Induced Peripheral Neuropathy: A Phase II Multicenter Study by the Kamigata Breast Cancer Study Group. Breast Cancer Research and Treatment, 160, 61-67. [Google Scholar] [CrossRef] [PubMed]
[22] Ohno, T., Mine, T., Yoshioka, H., et al. (2014) Management of Peripheral Neuropathy Induced by Nab-Paclitaxel Treatment for Breast Cancer. Anticancer Research, 34, 4213-4216.
[23] Smith, E.M.L., Pang, H., Cirrincione, C., et al. (2013) Effect of Duloxetine on Pain, Function, and Quality of Life among Patients with Chemotherapy-Induced Painful Peripheral Neuropathy: A Randomized Clinical Trial. JAMA: The Journal of the American Medical Association, 309, 1359-1367. [Google Scholar] [CrossRef] [PubMed]
[24] Wang, J., Li, Q., Xu, B., et al. (2017) Efficacy and Safety of Duloxe-tine in Chinese Breast Cancer Patients with Paclitaxel-Induced Peripheral Neuropathy. Chinese Journal of Cancer Re-search, 29, 411-418. [Google Scholar] [CrossRef] [PubMed]
[25] Loprinzi, C.L., Lacchetti, C., Bleeker, J., et al. (2020) Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 38, 3325-3348. [Google Scholar] [CrossRef
[26] Albers, J.W., et al. (2007) Interventions for Preventing Neuropathy Caused by Cisplatin and Related Compounds. The Cochrane Database of Systematic Reviews, No. 3, CD005228.
[27] Pachman, D.R., et al. (2011) Chemotherapy-Induced Peripheral Neuropathy: Prevention and Treat-ment. Clinical Pharmacology and Therapeutics, 90, 377-387.
[28] Zhu, J., Carozzi, V.A., Reed, N., et al. (2016) Eth-oxyquin Provides Neuroprotection against Cisplatin-Induced Neurotoxicity. Scientific Reports, 6, Article No. 28861. [Google Scholar] [CrossRef] [PubMed]
[29] 张振, 孙亚红, 安玉姬, 等. 补阳还五汤膏剂防治含紫杉醇方案化疗致外周神经毒性临床研究[J]. 山东中医杂志, 2017, 36(5): 383-384+389. [Google Scholar] [CrossRef
[30] 马飞, 罗扬, 李逸群. 乳腺癌中紫杉类药物临床应用专家共识[J]. 中国医学前沿杂志(电子版), 2020, 12(3): 31-40.
[31] Verstappen, C.C.P., et al. (2003) Neurotoxic Complications of Chemotherapy in Patients with Cancer: Clinical Signs and Optimal Management. Drugs, 63, 1549-1563. [Google Scholar] [CrossRef] [PubMed]
[32] Birch, S., Lee, M.S., Alraek, T., et al. (2019) Evidence, Safety and Recommendations for When to Use Acupuncture for Treating Cancer Related Symptoms: A Narrative Review. Integrative Medicine Research, 8, 160-166. [Google Scholar] [CrossRef] [PubMed]
[33] Vickers, A.J., Straus, D.J., Fearon, B., et al. (2004) Acupuncture for Postchemotherapy Fatigue: A Phase II Study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 22, 1731-1735. [Google Scholar] [CrossRef
[34] Huang, C.C., Ho, T.J., Ho, H.Y., et al. (2021) Acupuncture Re-lieved Chemotherapy-Induced Peripheral Neuropathy in Patients with Breast Cancer: A Pilot Randomized Sham-Controlled Trial. Journal of Clinical Medicine, 10, 3694. [Google Scholar] [CrossRef] [PubMed]
[35] Lu, W., Giobbie-Hurder, A., Freedman, R.A., et al. (2020) Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial. The Oncologist, 25, 310-318. [Google Scholar] [CrossRef] [PubMed]
[36] Seidman, A.D., Piulson, L., Vertosick, E., et al. (2018) A Phase IIA Trial of Acupuncture to Reduce Chemotherapy- Induced Peripheral Neuropathy Severity during Neoadjuvant or Adjuvant Weekly Paclitaxel Chemotherapy in Breast Cancer Patients. European Journal of Cancer, 101, 12-19.
[37] 刘柏, 张力文, 徐凯, 等. 针刺治疗化学治疗药物所致周围神经系统毒性的临床观察[J]. 河北中医, 2009, 31(7): 1040-1041.
[38] Park, J.H., Lee, J.S., Cho, C.K., et al. (2015) Electroacupuncture for the Treatment of the Chemothera-py-Induced Peripheral Neuropathy in Breast Cancer Patient: A Case Report. Journal of Korean Traditional Oncology, 20, 1-9. [Google Scholar] [CrossRef
[39] 韦海霞, 邓生明, 陆用连, 等. 电针艾灸联合紫杉醇治疗恶性肿瘤的临床研究[J]. 云南中医中药杂志, 2014, 35(9): 19-21. [Google Scholar] [CrossRef
[40] Zhao, X., Liu, L., Wang, Y., et al. (2019) Electroacu-puncture Enhances Antioxidative Signal Pathway and Attenuates Neuropathic Pain Induced by Chemotherapeutic Paclitaxel. Physiological Research, 68, 501-510. [Google Scholar] [CrossRef] [PubMed]
[41] Izgu, N., et al. (2019) Prevention of Chemotherapy-Induced Pe-ripheral Neuropathy with Classical Massage in Breast Cancer Patients Receiving Paclitaxel: An Assessor-Blinded Ran-domized Controlled Trial. European Journal of Oncology Nursing: The Official Journal of European Oncology Nursing Society, 40, 36-43. [Google Scholar] [CrossRef] [PubMed]
[42] 杨志峥, 宫深谋, 雷妍伟. 中西医结合治疗化疗引起的手足麻木临床研究[J]. 中医学报, 2011, 26(11): 1383-1384. [Google Scholar] [CrossRef
[43] 韩菲菲. 温经活血通络方外用治疗化疗导致周围神经病变的疗效初探[D/OL]: [硕士学位论文]. 广州: 广州中医药大学, 2011.
https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CMFD&dbname=CMFD2011&filename=1011136079.nh&v
[44] 贾玫, 李潇, 张宇, 等. 中药外用治疗化疗药物周围神经毒性21例疗效观察[J]. 肿瘤基础与临床, 2011, 24(2): 161-162.
[45] Zaheed, M., Wilcken, N., Willson, M.L., et al. (2019) Sequencing of Anthracyclines and Taxanes in Neoadjuvant and Adjuvant Therapy for Early Breast Cancer. The Cochrane Database of Systematic Reviews, 2, CD012873. [Google Scholar] [CrossRef